Form 4: MapLight Therapeutics Officer Sells Shares for Tax

MapLight Therapeutics' Chief Discovery Officer, Anatol Kreitzer, disposed of 42,099 common shares to satisfy tax withholding obligations.

Summary

• Anatol Kreitzer, Chief Discovery Officer of MapLight Therapeutics, Inc. (MPLT), reported a transaction involving company common stock.
• On January 27, 2026, 42,099 shares of Voting Common Stock were disposed of at a price of $17.98 per share.
• This disposition represents shares withheld by the Issuer to cover tax withholding obligations related to the settlement of restricted stock unit awards.
• Following this transaction, Anatol Kreitzer beneficially owns 253,908 shares of Voting Common Stock directly.
• The retained securities are subject to a 180-day lock-up agreement from the initial public offering's final prospectus date of October 26, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a mandatory disposition for tax purposes, not a discretionary sale, and therefore does not reflect management's sentiment towards the company's future prospects.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions and do not typically provide broader industry context. This specific filing details a common event related to executive compensation and tax obligations.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine tax-related transaction by an insider, not a discretionary sale. The lock-up agreement continues to restrict the sale of remaining shares.

Key Dates

Keywords

MapLight Therapeutics, MPLT, Anatol Kreitzer, Chief Discovery Officer, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Lock-up Agreement